Paper23345947
Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.
Shirin H and 4 others. World J Gastroenterol, 2013. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats. Papers, record 23345947. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23345947
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluorobenzenes | Major topic |
| Heptanoic Acids | Major topic |
| Liver Cirrhosis, Experimental | Major topic |
| Pyrimidines | Major topic |
| Pyrroles | Major topic |
| Sulfonamides | Major topic |
| Thioacetamide | Major topic |
| Animals | |
| Atorvastatin | |
| Cell Proliferation | |
| Cells, Cultured | |
| Disease Models, Animal | |
| Hepatic Stellate Cells | |
| Hypertension, Portal | |
| In Vitro Techniques | |
| Incidence | |
| Injections | |
| Liver Cirrhosis | |
| Male | |
| Oxidative Stress | |
| Rats | |
| Rats, Wistar | |
| Rosuvastatin Calcium |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12713866 | Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. | J Hepatol | 2003 | https://conductscience.org/library/papers/12713866 | PubMed |
| 2 | 7977754 | TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. | Am J Physiol | 1994 | https://conductscience.org/library/papers/7977754 | PubMed |
| 3 | 21749370 | Pravastatin for thioacetamide-induced hepatic failure and encephalopathy. | Eur J Clin Invest | 2012 | https://conductscience.org/library/papers/21749370 | PubMed |
| 4 | 10500210 | 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10500210 | PubMed |
| 5 | 16447273 | Alcohol and oxidative liver injury. | Hepatology | 2006 | https://conductscience.org/library/papers/16447273 | PubMed |
| 6 | 16139830 | Mechanisms of liver fibrosis. | Clin Chim Acta | 2006 | https://conductscience.org/library/papers/16139830 | PubMed |
| 7 | 19110552 | Cholesterol-induced stimulation of postinflammatory liver fibrosis. | Bull Exp Biol Med | 2008 | https://conductscience.org/library/papers/19110552 | PubMed |
| 8 | 28917 | Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. | Drug Metab Dispos | 1978 | https://conductscience.org/library/papers/28917 | PubMed |
| 9 | 11701455 | Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11701455 | PubMed |
| 10 | 13786180 | The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. | Arch Biochem Biophys | 1961 | https://conductscience.org/library/papers/13786180 | PubMed |
| 11 | 15289372 | Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. | Circulation | 2004 | https://conductscience.org/library/papers/15289372 | PubMed |
| 12 | 15824762 | Modulation of the inflammatory process by statins. | Timely Top Med Cardiovasc Dis | 2005 | https://conductscience.org/library/papers/15824762 | PubMed |
| 13 | 21276150 | Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats. | Hepatol Res | 2011 | https://conductscience.org/library/papers/21276150 | PubMed |
| 14 | 7593635 | Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7593635 | PubMed |
| 15 | 8175151 | Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? | Hepatology | 1994 | https://conductscience.org/library/papers/8175151 | PubMed |
| 16 | 7982659 | Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. | Hepatology | 1994 | https://conductscience.org/library/papers/7982659 | PubMed |
| 17 | 16724977 | Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. | J Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16724977 | PubMed |
| 18 | 12694870 | Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. | Biochem Pharmacol | 2003 | https://conductscience.org/library/papers/12694870 | PubMed |
| 19 | 9303494 | Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. | Hepatology | 1997 | https://conductscience.org/library/papers/9303494 | PubMed |
| 20 | 10412745 | Effect of simvastatin on proliferative nephritis and cell-cycle protein expression. | Kidney Int Suppl | 1999 | https://conductscience.org/library/papers/10412745 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35369681 | Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions. | Gastroenterology Res | 2022 | https://conductscience.org/library/papers/35369681 | PubMed |
| 34631742 | Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34631742 | PubMed |
| 30203151 | Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation. | Naunyn Schmiedebergs Arch Pharmacol | 2019 | https://conductscience.org/library/papers/30203151 | PubMed |
| 29326488 | Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses. | Indian J Pharmacol | 2017 | https://conductscience.org/library/papers/29326488 | PubMed |
| 28752475 | Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects. | Curr Gastroenterol Rep | 2017 | https://conductscience.org/library/papers/28752475 | PubMed |
| 27275221 | Lactoferrin Enhanced Apoptosis and Protected Against Thioacetamide-Induced Liver Fibrosis in Rats. | Open Access Maced J Med Sci | 2015 | https://conductscience.org/library/papers/27275221 | PubMed |
| 26891205 | Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES. | Hepatology | 2016 | https://conductscience.org/library/papers/26891205 | PubMed |
| 26779021 | Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. | Front Pharmacol | 2015 | https://conductscience.org/library/papers/26779021 | PubMed |
| 26427493 | Animal models of hepatotoxicity. | Inflamm Res | 2016 | https://conductscience.org/library/papers/26427493 | PubMed |
| 26217081 | Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26217081 | PubMed |
| 25135867 | Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C. | J Hepatol | 2015 | https://conductscience.org/library/papers/25135867 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23345947
GET https://conductscience.org/api/papers/v1/23345947/references?page=2